Small caps round-up: BioSeek, 21st Century, CareCapital...
BioSeek, a subsidiary of drugs developer Asterand, has signed a new three-year collaboration agreement with Merck Serono, a division of German pharmaceuticals giant firm Merck. The new agreement is for a research plan which extends and expands the companies' previous three-year agreement from 2009. The studies carried out by BioSeek for Merck Serono over the past three years have demonstrated that the BioMAP platform can be used to reliably advance promising molecules through pre-clinical evaluation, the company claimed.
BioSeek, a subsidiary of drugs developer Asterand, has signed a new three-year collaboration agreement with Merck Serono, a division of German pharmaceuticals giant firm Merck. The new agreement is for a research plan which extends and expands the companies' previous three-year agreement from 2009. The studies carried out by BioSeek for Merck Serono over the past three years have demonstrated that the BioMAP platform can be used to reliably advance promising molecules through pre-clinical evaluation, the company claimed.
21st Century, a supplier and installation service provider of public transport closed-circuit television, reported a leap in sales from £10.8m to £14m for 2011. Profit after tax doubled from £0.6m to £1.2m, while earnings per share rose from 0.61p to 1.31p. Year end cash was up to £2.8m from £1.1m at the start of the year. The firm said if the company continues to progress it will consider proposing a dividend within the next 12 months.
CareCapital, a property investment firm, has announced a restructing of the company to reflect its strategy to reposition the group as an investor in, and provider of, advanced cancer treatments. Current investments in medical centre development projects will be transferred to the group's wholly owned subsidiary, The Healthcare Property Company, while the firm itself will change its name to Advanced Oncotherapy. The will also be a change in management responsibilities, including the promotion of Lord Evans of Watford to non-executive Chairman.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Stockbroking firm Numis Securities is taking over the RBS Hoare Govett Smaller Companies Index. The index will be renamed "The Numis Smaller Companies Index" with immediate effect. Although no initial consideration is being paid, Numis will be paying ongoing fees and may make royalty-based payments to the compilers of the index. The index covers over 800 companies which make up the bottom 10% of the UK market by value.
Financial website operator ADVFN has announced an agreement with TheStreet to distribute TheStreet's content through its network of financial websites. ADVFN is expanding its global reach and currently has localised sites in numerous countries including the UK, US, France and Germany.
NR
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
What happens if you can’t pay your tax bill, and what is "Time to Pay"?
Millions are due to file their tax return this Friday as the self-assessment deadline closes. Though the nightmare is not over until you pay the taxman what you owe - or face a penalty. But what happens if you can't afford to pay HMRC your tax bill, and what is "Time to Pay"?
By Kalpana Fitzpatrick Published
-
What does Rachel Reeves’s plan for growth mean for UK investors?
Rachel Reeves says she is going “further and faster” to kickstart the UK economy, but investors are unlikely to be persuaded
By Katie Williams Published